||||||||||Trial withdrawal: A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome (clinicaltrials.gov) - Oct 22, 2014 P=N/A, N=0, Withdrawn, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting --> Completed Completed --> Withdrawn
||||||||||Trial completion: Prenatal Screening For Smith-Lemli-Opitz Syndrome (clinicaltrials.gov) - Feb 22, 2014 P2, N=1800, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Active, not recruiting --> Completed Recruiting --> Completed
||||||||||Trial completion: Cholesterol in ASD: Characterization and Treatment (clinicaltrials.gov) - Nov 14, 2013 P1/2, N=44, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Recruiting --> Completed Active, not recruiting --> Completed
||||||||||Enrollment change: Cholesterol in ASD: Characterization and Treatment (clinicaltrials.gov) - Mar 26, 2013 P1/2, N=44, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Active, not recruiting --> Completed N=900 --> 44
||||||||||lovastatin / Generic mfg. Trial withdrawal: Novel Treatment for Syndromic Ichthyoses (clinicaltrials.gov) - Nov 28, 2012 P2, N=0, Withdrawn, Sponsor: Northwestern University N=900 --> 44 Not yet recruiting --> Withdrawn
||||||||||lovastatin / Generic mfg. Enrollment change: Novel Treatment for Syndromic Ichthyoses (clinicaltrials.gov) - Nov 28, 2012 P2, N=0, Withdrawn, Sponsor: Northwestern University Not yet recruiting --> Withdrawn N=15 --> 0